Table 2.

Treatment outcomes of surgically treated patients for all patients and per group

	All, n = 8	Group 1, n = 5 Additional information	Group 2, n = 3 Radiological diagnosis
Confirmative immunohistochemistry	5 (62.5%)	3 (60.0%)	2 (66.7%)
Normalization prolactin	5 (62.5%)	2 (40.0%)	3 (100.0%)
IOQ
1	6 (75.0%)	3 (60.0%)	3 (100.0%)
2	1 (12.5%)	1 (20.0%)	0 (0.0%)
3	1 (12.5%)	1 (20.0%)	0 (0.0%)
4	0 (0.0%)	0 (0.0%)	0 (0.0%)
Clinical status
Improved	6 (75.0%)	3 (60.0%)	3 (100.0%)
Unchanged	1 (12.5%)	1 (20.0%)	0 (0.0%)
Worse	1 (12.5%)	1 (20.0%)	0 (0.0%)
Complications	2 (25.0%)	1 (20.0%)	1 (33.3%)
Transient	1 (12.5%)	0 (0.0%)	1 (33.3%)
Permanent	1 (12.5%)	1 (20.0%)	0 (0.0%)

Values are presented as median (range), or number (percentages)

IOQ integrated outcome quadrant: IOQ 1 – treatment goal achieved without permanent complications, IOQ 2 – treatment goal achieved with permanent complication, IOQ 3 – treatment goal not achieved, without permanent complications, IOQ 4 – treatment goal not achieved with permanent complications